Supplement makers may get temporary reprieve from FDA inspections
Jan 13, 2022
Larisa Pavlick is quoted:
“Within the UNPA family, we understand that most responsible and reputable companies will remain on course, and we will continue to be vigilant with appropriate GMP practices…Let’s use this time, free of audits and inspections, to focus and get better.”
She continues:
“Is it dangerous now that the FDA is not in the field?” asked Pavlick, a former FDA investigator with the Denver District office. “Is it more dangerous than it was before? No, in my opinion, because reputable and responsible companies have always focused on compliance and quality as part of the values of the organization and commitment to consumers.”
She added, “Nobody’s going to stay in business if they have poor-quality products that are hurting people.”
Loren Israelsen visits with Mike Kauffman, President of Facilities Consulting NW, and discusses the importance of facility design in achieving GMP compliance. Mike
The U.S. Food and Drug Administration (FDA) published a draft guidance on the submission of new dietary ingredient notification (NDIN) master files. The
